Researchers from across the globe gathered in the Reitz Union at the University of Florida for a three-day muscle biology conference last week.
Just 20 years ago, scientists didn’t even realize muscles had their own circadian clocks. Now they are beginning to appreciate their importance in health.
At the American Academy of Neurology 70th Annual meeting in Los Angeles on April 25, it was reported that the drug edasalonexent showed a remarkably favorable impact on the progression of Duchenne muscular dystrophy in 4- to 7-year-old boys (“MoveDMD trial”).
A pair of protein-inhibiting compounds is effective at slowing the progression of a form of muscular dystrophy in animal models, a group of University of Florida Health researchers has found.
The University of Florida welcomed more than 300 researchers from around the world for the Advances in Skeletal Muscle Biology in Health and Disease conference March 8-10 in Gainesville
When we exercise, a cascade of benefits occurs, but researchers don’t know exactly what happens in the body to cause those benefits. Now, two teams at the University of Florida have received a total of approximately $11.6 million out of a $170 million push from the National Institutes of Health to study the molecular changes that occur during physical activity.
A year after it was formed, the UF Myology Institute is gaining strength in the world of muscle biology research.
UF held its 14th Biennial Muscular Research Conference from Wednesday until today. The Advances in Skeletal Muscle Biology in Health and Disease symposium is an international conference on studying and combating muscle wasting diseases.
September 14, 2015 – Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center at UF Health
University of Florida Health has been designated by the National Institutes of Health as one of six centers to help translate scientific findings into strategies to improve the lives of muscular dystrophy patients. UF Health has received first-year funding of a 5-year, $10.76 million grant to study ways to address muscle degeneration caused by the disease.
December 9, 2014 – H. Lee Sweeney, Ph.D. joins the Department of Pharmacology as The Thomas H. Maren, M.D., Eminent Scholar Chair
The Department of Pharmacology is honored to welcome Dr. H. Lee Sweeney to the faculty. Dr. Sweeney will join the department as The Thomas H. Maren, M.D., Eminent Scholar Chair.